Advertisement

Donating Human Samples: Who Benefits? Cases from Iceland, Kenya and Indonesia

  • Julie Cook Lucas
  • Doris Schroeder
  • Gardar Arnason
  • Pamela Andanda
  • Joshua Kimani
  • Veronique Fournier
  • Meena Krishnamurthy
Chapter

Abstract

Benefit sharing involving human genetic resources is an unresolved topic. Some argue that participation in scientific research should always be altruistically motivated, which is how access to human genetic resources has historically been governed in affluent nations. However, uncritically transferring the altruism model to developing countries leads to the emergence of serious exploitation issues. This chapter illustrates the potential for exploitation and other associated ethical concerns through a discussion of three cases: The Icelandic deCODE biobank for genetic research; the sex workers from Nairobi, Kenya, whose samples are used for ongoing HIV/AIDS research; and the Indonesian government’s decision to withhold virus samples from the World Health Organization in order to achieve fairer benefit sharing. Public attention is captured more easily by global pandemics, but the case of the Nairobi sex workers illustrates that the exploitation issues raised on the international stage by the Indonesian government are not limited to virus sharing. A framework for equitable access to human genetic resources is urgently needed, but in order to ensure justice, this needs to be accompanied by sustained attention to benefit sharing.

Keywords

Benefit sharing Icelandic biobank  Majengo sex workers Indonesian virus samples Exploitation Human genetic resources HIV/AIDS 

References

  1. AAVP (2002) The Kenya AIDS Vaccine Initiative: Challenges and achievements. Newsletter of the African AIDS Vaccine Programme, 2Google Scholar
  2. Altman LK (1993) HIV immunity discussed at Berlin conference. New York Times, 9 June. http://www.nytimes.com/1993/06/09/world/hiv-immunity-discussed-at-berlin-conference.html
  3. Andanda P (2004) A golden chance for medical ethics in Kenya. SciDev.Net, 15 June. http://www.scidev.net/en/opinions/a-golden-chance-for-medical-ethics-in-kenya.html
  4. Andanda P (2005) Informed consent. Dev World Bioeth 5(1):14–29CrossRefGoogle Scholar
  5. Andanda P (2008) Human tissue related inventions: Ownership and intellectual property rights in international collaborative research in developing countries. J Med Ethics 34(3):171–179CrossRefGoogle Scholar
  6. Andanda P (2009) Vulnerability: Sex workers in Nairobi’s Majengo slum. Camb Q Healthc Ethics 18(2):138–146CrossRefGoogle Scholar
  7. Andanda P, Lucas JC (2007) Majengo HIV/AIDS research case. A report for GenBenefit. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_nairobi_case.pdf
  8. Árnason G (2004) Interbreeding within the Icelandic population is high compared to that of mice or fruit-flies. In: Árnason G, Nordal S, Árnason V (eds) Blood and data: Ethical, legal and social aspects of human genetic databases. University of Iceland Press, Reykjavik, pp 29–35Google Scholar
  9. Associated Press (1997) Nairobi prostitutes may hold key to AIDS vaccine. CNN, 25 Oct. http://www.cnn.com/HEALTH/9710/25/kenya.aids/index.html
  10. Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, Plummer FA (2007) Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 21(9):1091–1101CrossRefGoogle Scholar
  11. Bandewar SVS, Kimani J, Lavery JV (2010) The origins of a research community in the Majengo observational cohort study, Nairobi, Kenya. BMC Public Health 10(630). http://www.biomedcentral.com/1471-2458/10/630
  12. Berg K, Chadwick R (2001) Solidarity and equity: New ethical frameworks for genetic databases. Nat Rev Genet 2:318–321CrossRefGoogle Scholar
  13. Bergmann E (2010) How Iceland lost its soul. The Guardian, 13 April. http://www.guardian.co.uk/commentisfree/2010/apr/13/iceland-truth-committee-report
  14. Bonn Guidelines (2002) The Bonn Guidelines on Access to Genetic Resources and the Fair and Equitable Sharing of the Benefits Arising out of their Utilization. Secretariat of the Convention on Biological Diversity, Quebec. http://www.cbd.int/doc/publications/cbd-bonn-gdls-en.pdf
  15. Bower H (1998). Science: New hope. The Independent (London), 29 Nov. http://www.independent.co.uk/arts-entertainment/science-new-hope-1188207.html
  16. Caplan AL, Curry DR (2007) Leveraging genetic resources or moral blackmail? Indonesia and avian flu virus sample sharing. Am J Bioeth 7(11):1–2CrossRefGoogle Scholar
  17. Carlin J (2003) Hope for Aids cure as prostitutes defy virus in the slums. The Observer, 23 Nov. http://www.guardian.co.uk/world/2003/nov/23/kenya.aids
  18. Carmichael M (2010) The world’s most successful failure. Newsweek, 12 Feb (From the magazine issue dated 22 Feb 2010). http://www.newsweek.com/id/233494
  19. CIOMS (2002) International ethical guidelines for biomedical research involving human subjects. Council for International Organizations of Medical Sciences. http://www.cioms.ch/publications/layout_guide2002.pdf
  20. d’Adesky A, Jeffreys R (1999) The African connection: Sex workers provide clues for a vaccine. HIV+, 3 Mar. http://www.aegis.com/pubs/hivplus/issue3/ahead/african.html
  21. Daily Nation (2001) Kenyan AIDS Scientists Win Recognition Battle. Daily Nation, 30 Aug. http://www.nationaudio.com/News/DailyNation/Supplements/horizon/06092001/story2.htm
  22. Fang G, Kuiken C, Weiser B, Rowland-Jones S, Plummer F, Chen CH, Kaul R, Anzala AO, Bwayo J, Kimani J, Philpott SM, Kitchen C, Sinsheimer JS, Gaschen B, Lang D, Shi B, Kemal KS, Rostron T, Brunner C, Beddows S, Sattenau Q, Paxinos E, Oyugi J, Burger H (2004) Long-term survivors in Nairobi: Complete HIV-1 RNA sequences and immunogenetic associations. J Infect Dis 190(4):697–701CrossRefGoogle Scholar
  23. Fidler DP (2008) Influenza virus samples, international law, and global health diplomacy. Emerg Infect Dis 14(1):88–94CrossRefGoogle Scholar
  24. Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ, MacDonald KS, Ngugi EN, Plummer FA (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. The Lancet 348(9038):1347–1351CrossRefGoogle Scholar
  25. Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, Kimani J, Krausa P, Bwayo J, Simonsen JN, Shearer GM, Plummer FA (1998) HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retrovir 14(17):1521–1530CrossRefGoogle Scholar
  26. Fowke KR, Kaul R, Rosenthal KL, Oyugi J, Kimani J, Rutherford WJ, Nagelkerke NJ, Ball TB, Bwayo JJ, Simonsen JN, Shearer GM, Plummer FA (2000) HIV-1-specific cellular immune responses among HIV-1-resistant sex workers. Immunol Cell Biol 78(6):586–595CrossRefGoogle Scholar
  27. GenBenefit (2009) Consultative meeting proceedings, benefit sharing, pre- and post-study obligations in biomedical research. Fairview Hotel, Nairobi, Kenya, 27 May. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_final_nairobi_100909.pdf
  28. Gertz R (2004) An analysis of the Icelandic supreme court judgement on the Health Sector Database Act. SCRIPT-ed 1(2):241–258CrossRefGoogle Scholar
  29. Grady C (2001) Money for research participation: Does it jeopardize informed consent? Am J Bioeth 1(2):40–44CrossRefGoogle Scholar
  30. Gulcher J, Stefánsson K (1998) Population genomics: Laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med 36(8):523–527CrossRefGoogle Scholar
  31. Hammond E (2009) Some intellectual property issues related to H5N1 viruses, research, and vaccines. Third World Network, Penang. http://www.twnside.org.sg/title2/avian.flu/papers/patent.paper.pdf
  32. HUGO Ethics Committee (2000a) Editorial: Genetic benefit sharing. Science 290(5489):49Google Scholar
  33. HUGO Ethics Committee (2000b) Statement on benefit-sharing, 9 April. http://www.eubios.info/BENSHARE.htm
  34. Icelandic Parliament (1998) The Act on Health Sector Database, no. 139/1998. http://eng.velferdarraduneyti.is/acts-of-Parliament/nr/17659
  35. IRIN (2010) Indonesia: Bird flu cases down but risk remains high. Integrated Regional Information Networks, 18 Jan. http://www.irinnews.org/report.aspx?reportid=87771
  36. Jeffreys R (2001) Riddle women: Reports of progress toward understanding how some people appear to fight off HIV. The Body, November. http://www.thebody.com/content/art1571.html
  37. Ji H, Ball TB, Kimani J, Plummer FA (2004) Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencing. J Human Genet 49(10):528–535Google Scholar
  38. Jóhannesson GT (1999) Kári í jötunmóð. Nýja bókafélagið, ReykjavíkGoogle Scholar
  39. Kaul R, Dong T, Plummer FA, Kimani J, Rostron T, Kiama P, Njagi E, Irungu E, Farah B, Oyugi J, Chakraborty R, MacDonald KS, Bwayo JJ, McMichael A, Rowland-Jones SL (2001a) CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Investig 107(10):1303–1310CrossRefGoogle Scholar
  40. Kaul R, Rowland-Jones SL, Kimani J, Dong T, Yang HB, Kiama P, Rostron T, Njagi E, Bwayo JJ, MacDonald KS, McMichael AJ, Plummer FA (2001b) Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Investig 107(3):341–349CrossRefGoogle Scholar
  41. Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, Kiama P, Rutherford J, Njagi E, Mwangi F, Rostron T, Onyango J, Oyugi J, MacDonald KS, Bwayo JJ, Plummer FA (2001c) New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 79(1–2):3–13CrossRefGoogle Scholar
  42. Lavery JV, Bandewar SVS, Kimani J, Upshur, Ross EG, Plummer FA, Singer PA (2010) ‘Relief of oppression’: An organizing principle for researchers’ obligations to participants in observational studies in the developing world. BMC Public Health 10(384). http://www.biomedcentral.com/1471-2458/10/384
  43. MacKenzie D (2007) Indonesia resumes sharing bird flu virus samples. New Scientist, 27 Mar. http://www.newscientist.com/article/dn11474-indonesia-resumes-sharing-bird-flu-virus-samples.html
  44. Marchant GE (2005) Property rights and benefit-sharing for DNA donors? Jurimetrics 45:153–178Google Scholar
  45. Minister for Environment and Natural Resources (2006) The Environmental Management and Co-ordination (Conservation of Biological Diversity and Resources, Access to Genetic Resources and Benefit Sharing) Regulations, 2006. Issued under Legal Notice No. 160. Minister for Environment and Natural Resources, NairobiGoogle Scholar
  46. Ministry of Health (2005) Kenya national guidelines for research and development of HIV/AIDS vaccines, March. Kenya Ministry of Health, NairobiGoogle Scholar
  47. Okwemba A (2000) A history of exploitation. Daily Nation, 15 JulyGoogle Scholar
  48. Okwemba A (2004) AIDS vaccine fails crucial test. Daily Nation, 9 Feb. http://www.nationmedia.com/dailynation/printpage.asp?newsid=14807
  49. Potts J (2002) At least give the natives glass beads: An examination of the bargain made between Iceland and deCODE Genetics with implications for global bioprospecting. Va J Law Technol 7(3). http://www.vjolt.net/archives.php?issue=13
  50. Revill J (2008) Jakarta ends stand-off on bird flu vaccines. The Observer, 24 Feb. http://www.guardian.co.uk/world/2008/feb/24/indonesia.birdflu
  51. Roche (1998) Roche and DeCode Genetics Inc. of Iceland collaborate in genetic disease research. Roche – Corporate Media News, 2 Feb. Roche, Basel, SwitzerlandGoogle Scholar
  52. Rose H (2001) The commodification of bioinformation: The Icelandic Health Sector Database. Wellcome Trust, LondonGoogle Scholar
  53. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, Blanchard T, Ariyoshi K, Oyugi J, Ngugi E, Bwayo J, MacDonald KS, McMichael AJ, Plummer FA (1998a) Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Investig 102(9):1758–1765CrossRefGoogle Scholar
  54. Rowland-Jones S, Dong T, Krausa P, Sutton J, Newell H, Ariyoshi K, Gotch F, Sabally S, Corrah T, Kimani J, MacDonald K, Plummer F, Ndinya-Achola J, Whittle H, McMichael A (1998b) The role of cytotoxic T-cells in HIV infection. Dev Biol Stand 92:209–214Google Scholar
  55. Schroeder D, Lasén Diáz C (2006) Sharing the benefits of genetic resources: from biodiversity to human genetics. Dev World Bioeth 6(3):135–143CrossRefGoogle Scholar
  56. Sedyaningsih ER, Isfandari S, Soendoro T, Supari SF (2008) Towards mutual trust, transparency and equity in virus sharing mechanism: The avian influenza case of Indonesia. Ann Acad Med Singap 37(6):482–488Google Scholar
  57. Sheremeta L (2003) Population genetic studies: Is there an emerging legal obligation to share benefits? Health Law Rev 12(1):36–38Google Scholar
  58. Sigurdsson S (2003) Decoding broken promises. Open Democracy, 6 Mar. http://www.opendemocracy.net/theme_9-genes/article_1024.jsp
  59. Simm K (2007) Benefit sharing frameworks: Justifications for and against benefit sharing in human genetic research. A report for GenBenefit. http://www.uclan.ac.uk/schools/school_of_health/research_projects/files/health_genbenefit_simm.pdf
  60. Snorrason E (1998) Free medications for Icelanders harm their health. Letter to the parliamentary committee on health, 11 Nov. http://www.mannvernd.is/frettir/22.11.1998_okeypis_lyf_ernir_snorrason.html
  61. Turner M (2000) Universities’ rift over Aids vaccine defused. Financial Times, 23 Oct. http://www.aegis.com/news/ads/2000/AD001902.html
  62. TWN (2010) WHO: Virus-Benefit Sharing Working Group set up, pandemic flu response to be reviewed. TWN Info Service on Health Issues, 27 Jan. Third World NetworkGoogle Scholar
  63. TWN (2011a) Agreement on influenza virus sharing and benefit sharing is a step forward but has some shortcomings. TWN Info Service on Health Issues, 20 April. Third World Network. http://www.twnside.org.sg/title2/health.info/2011/health20110402.htm
  64. TWN (2011b) ‘Milestone’ virus/benefit-sharing agreement with shortcomings. TWN Info Service on Health Issues, 25 April. Third World Network. http://www.twnside.org.sg/title2/health.info/2011/health20110404.htm
  65. UNAIDS (2000) Ethical considerations in HIV preventive vaccine research. UNAIDS guidance document, May. Joint United Nations Programme on HIV/AIDS, Geneva. http://data.unaids.org/publications/IRC-pub01/JC072-EthicalCons_en.pdf
  66. UNESCO (1997) Universal Declaration on the Human Genome and Human Rights. United Nations Educational, Scientific and Cultural Organization. http://www.un-documents.net/udhghr.htm
  67. UNESCO (2005) Universal Declaration on Bioethics and Human Rights. Adopted by the General Conference of the United Nations Educational, Scientific and Cultural Organization, 33rd Session, 19 Oct. http://portal.unesco.org/en/ev.php-URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html
  68. Vaiman V, Davídsson PÁ, Sigurjónsson TO (2010) Revising a concept of corruption as a result of the global economic crisis: The case of Iceland. In: Stachowicz Stanusch A (ed) Organizational immunity to corruption: Building theoretical and research foundations. Polish Academy of Science Commission Regional Departure, Katowice, pp 363–372Google Scholar
  69. Wade R (2009) Iceland as Icarus. Challenge 52(3):5–33CrossRefGoogle Scholar
  70. Waldholz M (2004) AIDS vaccine disappoints in tests: Experimental grug failed to show robust response in human immune system. Wall Street J, 3 Sept. http://www.aegis.com/news/wsj/2004/WJ040901.html
  71. WHO (2005a) Guidance for the timely sharing of influenza viruses/specimens with potential to cause human influenza pandemics, March. World Health Organization, GenevaGoogle Scholar
  72. WHO (2005b) Revision of the International Health Regulations, 23 May. WHA58.3. World Health OrganizationGoogle Scholar
  73. WHO (2007a) Avian and pandemic influenza: Developments, response and follow-up, and application of the International Health Regulations (2005): Best practice for sharing influenza viruses and sequence data. Report by the Secretariat. Provisional agenda item 4.4, Executive Board 120th Session. EB120/INF.DOC./3, 11 Jan. World Health Organization. http://www.who.int/gb/ebwha/pdf_files/EB120/b120_id3-en.pdf
  74. WHO (2007b) Avian and Pandemic Influenza. Provisional agenda item 12.1, Sixtieth World Health Assembly. A60/INF.DOC./2, 22 Mar 2007. World Health OrganizationGoogle Scholar
  75. WHO (2007c) The World Health Report 2007 – A safer future: Global public health security in the 21st century. World Health Organization, Geneva. http://www.who.int/whr/2007/07_overview_en.pdf
  76. WHO (2007d) Pandemic influenza preparedness: Sharing of influenza viruses and access to vaccines and other benefits. Agenda item 12.1, Sixtieth World Health Assembly. WHA60.28, 23 May. World Health OrganizationGoogle Scholar
  77. WHO (2008) What are the International Health Regulations? Online Q&A, 10 April. World Health Organization. http://www.who.int/features/qa/39/en/index.html
  78. WHO (2009) Pandemic influenza preparedness: Sharing of influenza viruses and access to vaccines and other benefits. Agenda item 12.1, Sixty-Second World Health Assembly. WHA62.10, 22 May. World Health OrganizationGoogle Scholar
  79. WHO (2010) Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. Agenda item 11.1, Sixty-Third World Health Assembly. WHA63.1, 19 May. World Health OrganizationGoogle Scholar
  80. WHO (2011a) Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. PIP/OEWG/3/4. World Health Organization. http://www.who.int/entity/csr/disease/influenza/pip_framework_16_april_2011.pdf
  81. WHO (2011b) H5N1 avian influenza: Timeline of major events, 14 July. World Health Organization. http://www.who.int/csr/disease/avian_influenza/ai_timeline/en/index.html
  82. Wilke M (2011) A plea for coherence where there is incoherence: The Nagoya Protocol, WHO and WIPO. Fairness and Bio-Knowledge, the Nagoya Protocol, Workshop at the School of Law, University of Warwick, 17 JuneGoogle Scholar
  83. Williams G, Schroeder D (2004) Human genetic banking: Altruism, benefit and consent. New Genet Soc 23(1):89–103Google Scholar
  84. WIPO (2007) Working paper: Patent issues related to influenza viruses and their genes. World Intellectual Property Organization. http://www.who.int/csr/disease/avian_influenza/wipo_ipdoc/en/index.html
  85. WMA (2008) Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted by the 18th World Medical Association General Assembly, Helsinki, Finland, June 1964, latest revision by the 59th WMA General Assembly, Seoul, Korea, October. http://www.wma.net/en/30publications/10policies/b3/index.html
  86. Wulandari F, Pathoni A (2007) Indonesia to resume sharing bird flu virus samples. Reuters, 27 Mar.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Julie Cook Lucas
    • 1
  • Doris Schroeder
    • 1
  • Gardar Arnason
    • 2
  • Pamela Andanda
    • 3
  • Joshua Kimani
    • 4
  • Veronique Fournier
    • 5
  • Meena Krishnamurthy
    • 6
  1. 1.UCLANCentre for Professional EthicsPrestonUK
  2. 2.Institut für PhilosophieLeibniz Universität HannoverHannoverGermany
  3. 3.School of LawUniversity of the WitwatersrandJohannesburgSouth Africa
  4. 4.Kenya AIDS Control Project, Institute of Tropical and Infectious Diseases, College of Health SciencesUniversity of NairobiNairobiKenya
  5. 5.Centre d’éthique CliniqueHôpital CochinParisFrance
  6. 6.Department of Philosophy, Centre for Professional and Applied EthicsUniversity of ManitobaWinnipegCanada

Personalised recommendations